|Up a level|
Berwick, D.C. and Calissano, M. and Corness, J.D. and Cook, S.J. and Latchman, David S. (2009) Regulation Of Brn-3a N-terminal transcriptional activity by MEK1/2-ERK1/2 signalling in neural differentiation. Brain Research 1256 , pp. 8-18. ISSN 0006-8993.
Bourke, L.T. and Knight, R,A, and Latchman, David S. and Stephanou, A. and McCormick, J. (2013) Signal transducer and activator of transcription-1 localizes to the mitochondria and modulates mitophagy. JAK-STAT 2 (4), e25666. ISSN 2162-3988.
Diss, J.K.J. and Calissano, M. and Gascoyne, D.M. and Djamgoz, M.B.A. and Latchman, David S. (2008) Identification and characterization of the promoter region of the Nav1.7 voltage-gated sodium channel gene (SCN9A). Molecular and Cellular Neuroscience 37 (3), pp. 537-547. ISSN 1044-7431.
Gandhi, S. and Wood-Kaczmar, A. and Yao, Z. and Plun-Favreau, H. and Deas, E. and Klupsch, K. and Downward, J. and Latchman, David S. and Tabrizi, S.J. and Wood, N.W. and Duchen, M.R. and Abramov, A.Y. (2009) PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-Induced Cell Death. Molecular Cell 33 (5), pp. 627-638. ISSN 1097-2765.
Gascoyne, D.M. and Dunne, J. and Behjati, S. and Sebire, N.J. and Anderson, J. and Latchman, David S. (2010) EWS/ETS proteins promote expression and regulate function of the homeodomain transcription factor BRN3A. Oncogene 29 (21), pp. 3134-3145. ISSN 0950-9232.
Latchman, David S. (2013) Eukaryotic transcription factors. In: Maloy, S. and Hughes, K. (eds.) Brenner's Encyclopedia of Genetics. New York, U.S.: Elsevier, pp. 537-539. ISBN 9780080961569.
Ndisang, D. and Faulkes, D.J. and Gascoyne, D.M. and Lee, S.A. and Ripley, B.J. and Sindos, M. and Singer, A. and Budhram-Mahadeo, V. and Cason, J. and Latchman, David S. (2006) Differential regulation of different human papilloma virus variants by the POU family transcription factor Brn-3a. Oncogene 25 (1), pp. 51-60. ISSN 0950-9232.
Ndisang, D. and Lorenzato, F. and Sindos, M. and Khan, A. and Singer, A. and Latchman, David S. (2009) The HPV cellular transactivator Brn-3a can be used to predict cervical adenocarcinoma and squamous carcinoma precancer lesions in the developed and developing worlds. Obstetrics and Gynecology International , ISSN 1687-9589.
Ndisang, D. and Lorenzato, F. and Sindos, M. and Singer, A. and Latchman, David S. (2006) Detection of cervical abnormalities in a developing country using measurement of Brn-3a in cervical smears. Gynecologic Oncology 100 (1), pp. 89-94. ISSN 0090-8258.